Diana X. Nichols-Vinueza, MD^1*, Nirali N. Shah, MD², Jennifer Cuellar-Rodriguez, MD^3*, Thomas R. Bauer Jr., PhD^4*, Katherine Calvo, MD, PhD^5,6, Luigi D. Notarangelo, MD^1*, Steven M. Holland, MD^7* and Dennis D. Hickstein, MD⁴

¹Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
²Pediatric Oncology Branch, National Cancer Institute/Nih, Bethesda, MD
³LCIM, NIAID, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
⁴Immune Deficiency-Cellular Therapy Program, National Cancer Institute, Bethesda, MD
⁵Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD
⁶Hematology Section, Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD
⁷NIAID/NIH, Bethesda, MD

Ben Watkins, MD^1,2,3, James Kaminski^4*, Muna Qayed, MD, MSc⁵, Kayla Betz, BS^6*, Yvonne Suessmuth, PhD^3*, Brandi Bratrude^7*, Alison Yu, PhD^4*, Victor Tkachev, PhD^8,9*, Kathryn Pellegrini^10*, Steven Bosinger, PhD^3*, Bruce R. Blazar, MD¹¹, John T. Horan, MD MPH¹², Amelia Langston, MD^13,14 and Leslie Kean, MD, PhD¹²

¹Aflac Cancer and Blood Disorders Center, Atlanta, GA
²Children's Healthcare of Atlanta, ATLANTA, GA
³Emory University, Atlanta, GA
⁴Boston Children's Hospital, Boston
⁵Pediatric Blood and Marrow Transplantation Program, Aflac Cancer and Blood Disorders Center, Emory University and Children’s Healthcare of Atlanta, Atlanta, GA
⁶Dana-Farber Cancer Institute, Boston Children's Hospital, boston
⁷Dana-Farber Cancer Institute, Boston Children's Hospital, Boston
⁸Department of Pediatrics, Harvard Medical School, Boston, MA
⁹Boston Children's Hospital, Boston, MA
¹⁰Emory University, Atlanta
¹¹Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN
¹²Dana-Farber Cancer Institute, Boston Children's Hospital, Boston, MA
¹³Winship Cancer Institute, Atlanta, GA
¹⁴Hematology and Medical Oncology, Emory University, Atlanta, GA

Rohtesh S. Mehta, MD, MPH, MS¹, Rima M. Saliba, PhD^2*, Anna Jan^3*, Terri Lynn Shigle, PharmD^4*, Emily Wang^3*, Gabriela Rondon², Yago Nieto, MD⁵, Stefan Ciurea, MD⁶, Betul Oran, MD, MS⁷, Jin S. Im¹, Amanda L. Olson¹, David Marin², Muzaffar H. Qazilbash, MD², Issa F. Khouri, MD², Paolo Anderlini⁸, Katayoun Rezvani, MD, PhD², Uday R. Popat, MD¹, Partow Kebriaei, MD², Elizabeth J. Shpall, MD², Richard E. Champlin, MD² and Amin M. Alousi, MD⁹

¹Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
³MD Anderson Cancer Center, Houston, TX
⁴Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Stem Cell Transplantation and Cellular Therapy, UT M.D. Anderson Cancer Ctr., Houston, TX
⁶University of California, Irvine, Orange, CA
⁷Stem Cell Transplantation and Cellular Therapy, The University of Texas, MD Anderson Cancer Center, Houston, TX
⁸Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁹Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX

Natasia Rodriguez, BSN^1*, Jasme Lee^2*, Lisa Flynn^1*, Fiona Murray^1*, Sean Devlin, PhD^2*, Cristina Soto Izquierdo^1*, Christina Cho, MD^1,3, Parastoo B. Dahi, MD^1,3, Sergio A. Giralt, MD^1,3, Craig S. Sauter, MD^1,3, Miguel-Angel Perales, MD^1,3 and Doris M Ponce, MD^1,3

¹Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Medicine, Weill Cornell Medical College, New York, NY

Yu Zhang^1*, Shaozhen Chen^1*, Jinhua Ren^1*, Xiaofeng Luo^1*, Zhizhe Chen^1*, Jianda Hu, MD, PhD¹ and Ting Yang, MD, PhD²

¹Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fuzhou, China
²Department of Hematology, Fujian Medical University Union Hospital，Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fuzhou, China

Andrew E. O. Hughes^1*, Maureen C. Montgomery^2*, Chang Liu^3* and Eric T. Weimer^2,4*

¹Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO
²Molecular Immunology Laboratory, McLendon Clinical Laboratories, University of North Carolina Hospitals, Chapel Hill, NC
³Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO
⁴Department of Pathology & Laboratory Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC

He Huang, MD, PhD¹, Yanmin Zhao, MD^1,2*, Guifang Ouyang^3*, Jimin Shi, MD^4,5*, Yi Luo, MD^1,2*, Yamin Tan, MD^1,2*, Jian Yu, MD^2*, Huarui Fu, MD^6*, Xiaoyu Lai, MD^1,2,5* and Lizhen Liu, MD^1,4,5*

¹Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, China
²Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
³Department of hematology, Ningbo Hospital of Zhejiang University, Ningbo, China
⁴Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁵Institute of Hematology, Zhejiang University, Hangzhou, China
⁶The First Affiliated Hospital of Zhejiang University, Hangzhou, CHN

Fiona See, PhD^1*, Karen Segal, PhD^2*, Paul Simmons, PhD^3* and Joanne Kurtzberg, MD⁴

¹Mesoblast, New York, NY
²Mesoblast Inc., New York, NY
³Mesoblast Ltd, Melbourne, AUS
⁴Pediatric Stem Cell Transplantation Department, Duke University Medical Center, Durham, NC

Jennifer White^1*, Nada Hamad, MBBS, BSc, MSc, FRACP FRCPA², Swe Mar Linn, MBBS³, Igor Nicolas Novitzky-Basso, MD, PhD, MRCP, FRCPath³, Omar Abduljalil^3*, Arjun Law, MD^3* and Dennis Dong Hwan Kim, MD⁴

¹British Columbia Cancer Agency, Vancouver General Hospital, Vancouver, Canada
²Department of Haematology, St Vincent's Hospital, Sydney, Australia
³Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
⁴Hans Messner Allogeneic Blood and Marrow Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada

Grigori Okoev, MD, PhD¹, Daniel J. Weisdorf, MD², John E Wagner, MD³, Bruce R. Blazar, MD³, Margaret L. MacMillan, MD³, Todd E. DeFor, MS^4*, Aleksandr Lazaryan, MD, PhD, MPH⁵, Najla H El Jurdi, MD⁶, Shernan G Holtan, MD⁶, Claudio G. Brunstein, MD, PhD⁶, Brian C. Betts, MD⁶, Takuto Takahashi, MD³, Veronika Bachanova, MD, PhD⁶, Erica D. Warlick, MD⁶, Armin Rashidi, MD, PhD⁶ and Mukta Arora, MD⁶

¹Division of Hematology, Oncology and Transplantation, University of Minnesota, Edina, MN
²Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
³Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN
⁴Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN
⁵Hematology, Oncology and Transplantation, Moffitt Cancer Center, Tampa, FL
⁶Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN

Hengwei Wu, MD^1,2*, Jimin Shi, MD^2,3*, Yi Luo, MD^1,2*, Yamin Tan, MD^1,2*, Mingming Zhang, MD^1*, Xiaoyu Lai, MD^1,2*, Jian Yu, MD^1*, Lizhen Liu, MD^2,3*, Huarui Fu, MD^1,2*, He Huang, MD, PhD^1,2 and Yanmin Zhao, MD^1,2*

¹Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
²Institute of Hematology, Zhejiang University, Hangzhou, China
³Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Andre Domingues Pereira, MD^1,2*, Vinicius Campos de Molla, MD³, Ana Rita Da Fonseca, MD^4*, Yana Novis, MD^2*, Marcela Souza Pires^5*, Ana Popi, PhD^6* and Celso Arrais-Rodrigues, MD, PhD^7,8

¹UNIVERSIDADE FEDERAL DE SAO PAULO, SAO PAULO, Brazil
²Hospital Sírio-Libanês, São Paulo, Brazil
³Universidade Federal de São Paulo, Unifesp, São Paulo, Brazil
⁴Department of Hematology and Hemotherapy, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil
⁵UNIFESP, São Paulo, Brazil
⁶UNIFESP, Sao Paulo, Brazil
⁷Centro de Oncologia, Hospital Sírio Libanês, São Paulo, Brazil
⁸Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil

Akanksha Chichra, DNB^1,2*, Sachin Punatar^1,2*, Anant Gokarn, MD, DM^1,2*, Sumeet Prakash Mirgh, MD, DM^1,2*, Vijay Shirure, MD, DM^1,2*, Vinodhini Murugaiyan^1,2*, Avinash Bonda, MD, DM^1,2*, Lingaraj Nayak, MD, DM^1,2*, Bhausaheb Bagal, MD, DM^1,2*, Sadhana Kannan, MSc^2,3*, Libin J Mathew, BSc^4*, Tapan Saikia, MD⁵ and Navin Khattry, MD, DM^1,2*

¹Bone Marrow Transplant Unit, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre., Navi Mumbai., India
²Homi Bhabha National Institute., Mumbai., India
³Tata Memorial Centre., Department of biostatistics., Navi Mumbai., India
⁴Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
⁵Prince Aly Khan Hospital, Mumbai, India